Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study

BACKGROUND: Prokineticin 1 (PROK1) was reported as an angiogenic factor, which is associated with tumor progression, cell invasion, and metastasis in colorectal cancer. Although the association between PROK1 expression in primary cancer lesion and patient prognosis was reported, it is unclear whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagai, Noriyuki, Goi, Takanori, Shimada, Michiaki, Kurebayashi, Hidetaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522247/
https://www.ncbi.nlm.nih.gov/pubmed/34657605
http://dx.doi.org/10.1186/s12957-021-02421-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522247/
https://www.ncbi.nlm.nih.gov/pubmed/34657605
http://dx.doi.org/10.1186/s12957-021-02421-0

Ejemplares similares